Skip to main content
VCbacked
Log inGet Started

Reneo Pharmaceuticals

San Diego, United States

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

$55.0M raised
May 2023
Post-IPO Equity
BiotechnologyMedicalPharmaceutical

Top Investors

New Enterprise AssociatesAbingworthRock Springs CapitalRiverVestAisling Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reneo Pharmaceuticals

How much funding has Reneo Pharmaceuticals raised?
Reneo Pharmaceuticals has raised $55.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2023.
Who are Reneo Pharmaceuticals's investors?
Reneo Pharmaceuticals's investors include New Enterprise Associates, Abingworth, Rock Springs Capital, RiverVest, Aisling Capital.
Where is Reneo Pharmaceuticals headquartered?
Reneo Pharmaceuticals is headquartered in San Diego, United States.
What does Reneo Pharmaceuticals do?
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
What stage is Reneo Pharmaceuticals at?
Reneo Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reneo Pharmaceuticals — Funding & Investors." VCBacked, May 3, 2023, https://www.vcbacked.co/company/reneo-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2023). Reneo Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/reneo-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Reneo Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/reneo-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K